efatutazone has been researched along with Triple-Negative-Breast-Neoplasms* in 1 studies
1 other study(ies) available for efatutazone and Triple-Negative-Breast-Neoplasms
Article | Year |
---|---|
An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer.
AIB1Δ4 is an N-terminally truncated isoform of the oncogene amplified in breast cancer 1 (AIB1) with increased expression in high-grade human ductal carcinoma Topics: Animals; Cell Culture Techniques, Three Dimensional; Cell Line, Tumor; CRISPR-Cas Systems; Dexamethasone; Disease Progression; Electric Impedance; Enhancer Elements, Genetic; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Nuclear Receptor Coactivator 3; Phenotype; Protein Isoforms; Receptors, Glucocorticoid; RNA Splicing; Signal Transduction; Thiazolidinediones; Triple Negative Breast Neoplasms; Zebrafish | 2021 |